Bullous hemorrhagic dermatosis: A rare cutaneous reaction of heparin.

J Postgrad Med

Department of Dermatology and STD, V.M.M.C. and Safdarjung Hospital, New Delhi, India.

Published: April 2023

Bullous hemorrhagic dermatosis is a rare cutaneous reaction of heparin, a commonly used anticoagulant. Exact etiopathogenesis remains elusive but immune related mechanisms as well as dose dependent relationship have been proposed. Clinically, it is characterized by asymptomatic, tense hemorrhagic bullae on extremities or abdomen occurring 5-21 days after initiation of therapy. We report bilateral symmetrically grouped lesions, in a previously unreported distribution of this entity in both the forearms in a 50-year-old male admitted with acute coronary syndrome on oral ecosprin, oral clopidogrel and subcutaneous enoxaparin. The condition is self-resolving and discontinuation of drug is not required.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259437PMC
http://dx.doi.org/10.4103/jpgm.jpgm_282_22DOI Listing

Publication Analysis

Top Keywords

bullous hemorrhagic
8
hemorrhagic dermatosis
8
dermatosis rare
8
rare cutaneous
8
cutaneous reaction
8
reaction heparin
8
heparin bullous
4
heparin commonly
4
commonly anticoagulant
4
anticoagulant exact
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!